Menu

利伐沙班治疗效果好吗?有哪些需要注意的

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

Rivaroxaban blocks the coagulation cascade and prevents thrombosis by binding to factor Xa and inhibiting its action. The advantages of this drug are: high bioavailability, long action time, safety and effectiveness. Compared with traditional warfarin, rivaroxaban does not require monitoring of coagulation. Is the treatment effective? What should we pay attention to?

Eisenberg MJ et al. meta-analyzed five randomized controlled studies (a total of 23,063 patients were included, including 3,967 cases of deep vein thrombosis, 14,264 cases of non-valvular atrial fibrillation, and 3,967 cases of acute symptomatic pulmonary embolism, all taking Rivaroxaban for ≥1 month). The results showed that compared with vitamin K antagonists, Rivaroxaban did not increase the composite endpoint of major bleeding and clinically relevant bleeding. Moreover, fatal bleeding events were significantly reduced in the Rivaroxaban group. The drug has significant therapeutic effects, can improve the patient's quality of life, and has a positive effect on the patient's condition.

Rivaroxaban Precautions

Rivaroxaban may cause fetal toxicity and harm the fetus, so patients should use effective contraception during treatment with this drug. Pregnant patients should inform their doctor before treatment, and the doctor will propose the best treatment plan based on the patient's condition. Treatment with Rivaroxaban is not recommended for breast-feeding patients.

Rivaroxaban may cause drug interactions. To avoid drug interactions, if patients are taking other drugs, please inform their physician or pharmacist before receiving this drug. A professional doctor will adjust the medication according to the patient's condition.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

  Recommended related articles:

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。